Gilead Sciences’ remdesivir cuts COVID-19 death risk in patients on low-flow oxygen esagonowsky Fri, 10/09/2020 – 09:30

U.K. manufacturer Abzena pumps $60M into new biologics facility in San Diego kblankenship Fri, 10/09/2020 – 08:46

Multidisciplinary tumor boards are vital to cancer treatment plans, bringing together clinicians from different specialties to guide patient […]

There is great potential in gene therapy for treating certain types of cancer and genetic defects, immunological diseases, […]

Brain science is still in a discovery phase because of our limited knowledge of basic nervous system structure […]

Cerebrovascular diseases and dementia are two leading contributors to impairment of brain health and neurological disability in older […]

Monogenic diseases result from modifications to a single gene. Over 10 000 monogenic diseases have been identified, around […]

Fadraciclib has passed safety trials and shown early efficacy

Partnership will aim to prevent cardiovascular events across the North West Coast of England

Testing Alliance created to offer 20,500 extra coronavirus tests a day